Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2)

NCT05142514 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

629

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
SARS-CoV-2 Acute Respiratory Disease

Interventions

BIOLOGICAL: COVID-19 Vaccine HIPRA
BIOLOGICAL: Cominarty (Pfizer-BioNtech)

Sponsor

Hipra Scientific, S.L.U

Collaborators

[object Object]
[object Object]